Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
Login | Create an Account

Emergency Medicine Pharmacotherapy with Resuscitation (EMPoweRx) Conference (Virtual)


March 11-12, 2022
Virtual Conference
 
 
To register: Click Here!
 
To visit the EMPoweRx website: click here!
 
To view Flyer: Click here
 
For questions contact support@empowerx-conference.com
 
Fees: $75 Pharmacists, $30 Pharmacy Residents
 
This conference is specifically designed for Pharmacists, Pharmacy Residents, Students, Physicians, Physician Assistants, Nurses, and Nurse Practitioners, who manage critically ill patients in the emergency department.
 
Program Description
Emergency medicine pharmacotherapy has been one of the most explosive specialties within clinical pharmacy over the past 20 years. While still new, emergency medicine pharmacists and pharmacotherapy has not had its own platform to present the latest evidence and issues facing emergency medicine pharmacy, until now. The EmpoweRx conference is a hybrid conference that is designed solely by practicing emergency medicine pharmacists and will include a multidisciplinary and multispecialty speaker lineup to present on the latest in resuscitation, emergency medicine pharmacotherapy, and administrative issues that are unique to the ED. We are excited to partner with Pharmacy & Acute Care University and the Pharm So Hard Podcast to spread the multimedia capacity of the conference.
 
Join us for the most inspiring, energizing, and educational international event in emergency medicine pharmacotherapy.
 
To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page. 
Clicking on the blue bars will expand the session details!

Date: Mar 11, 2022 01:00 PM - Mar 12, 2022 06:00 PM

CE Hours

8.00

CE Units

0.800

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

EMPoweRx Committee

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified. To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.

 

 

 

 

At the completion of this activity, the participant will be able to:
  1. Recognize different etiologies and forms of ventricular tachycardia (VT)
  2. Analyze different pharmacological options for treating VT

Speaker(s)/Author(s)

Lance Ray, PharmD, BCPS
Clinical Pharmacy Specialist, Emergency Medicine, Denver Health

Activity Number

0062-9999-22-049-L01-P
Date: 03/11/22
Time: 01:00 PM - 01:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Review current guideline recommendations for the treatment of paroxysmal supraventricular tachycardia (pSVT)
  2. Recognize why adenosine may no longer be the only first-line pharmacologic therapy
  3. Appraise the current available evidence for calcium channel blockers (CCB) in pSVT
  4. Discuss scenarios when not to use either agent

Speaker(s)/Author(s)

Nicholas Servati, PharmD, BCCP
Clinical Pharmacy Specialist, Cardiovascular ICU, UMass Memorial Medical Center

Activity Number

0062-9999-22-050-L01-P
Date: 03/11/22
Time: 01:30 PM - 02:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Summarize the value of a local emergency department antibiogram
  2. Recognize potential short falls of select antibiotics, and assess potential alternatives for community acquired pneumonia, urinary tract infections, and skin and soft tissue infections
  3. Recognize opportunities to shorten antibiotic therapy duration for select infectious processes

Speaker(s)/Author(s)

Mark Anthony Mixon, PharmD, BCPS, BCIDP, BCCCP
Emergency Medicine Clinical Pharmacist, University of Colorado Health- North Region

Activity Number

0062-9999-22-051-L01-P
Date: 03/11/22
Time: 02:00 PM - 02:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Discuss coagulation and risk factors for coagulopathy
  2. Describe the use of viscoelastic tests in critically ill emergency department (ED) patients

Speaker(s)/Author(s)

Megan A Rech, PharmD, MS, BCCCP, FCCM
Affiliate Assistant Professor & Research Director, Department of Emergency Medicine, Stritch School of Medicine, Loyola University Chicago

Activity Number

0062-9999-22-052-L01-P
Date: 03/11/22
Time: 02:30 PM - 03:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Assess systemic fibrinolytic strategies for acute ischemic stroke
  2. Compare pharmacologic differences between alteplase and tenecteplase
  3. Evaluate literature supporting current guideline recommendations for both alteplase and tenecteplase

Speaker(s)/Author(s)

James Priano, PharmD, BCPS
Clinical Pharmacy Specialist, Emergency Medicine, AdventHealth Orlando

Activity Number

0062-9999-22-053-L01-P
Date: 03/11/22
Time: 04:00 PM - 04:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Discuss the epidemiology, pathophysiology, and risk stratification of pulmonary embolisms (PE)
  2. Review bedside tools and strategies used to narrow the presentation differential
  3. Examine treatment options for the management of massive PE

Speaker(s)/Author(s)

Terren Trott, MD
Enterprise Point of Care Ultrasound Director, Enterprise Point of Care Ultrasound Director, University of Kentucky; Dual appointment in the Department of Pulmonary, Critical Care and Sleep Medicine and Emergency Medicine, University of Kentucky

Activity Number

0062-9999-22-054-L01-P
Date: 03/11/22
Time: 04:30 PM - 05:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Describe the important differences between antivenom products
  2. Debate whether Copperheads should be considered in a different category to other pit vipers for the purposes of antivenom treatment and outcome measurement
  3. Critique the definition of "initial control"

Speaker(s)/Author(s)

Craig Cocchio, PharmD, BCPS, DABAT
Emergency Medicine Clinical Pharmacist, Residency Program Director, Emergency Medicine PGY2, CHRISTUS Trinity Mother Frances Health System

Activity Number

0062-9999-22-055-L01-P
Date: 03/11/22
Time: 05:00 PM - 05:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Explain the rationale for the original intravenous NAC dosing regimen in the UK, the original oral regimen using the FDA approved inhalational product in the US and current practices utilizing varying routes, numbers of intravenous bags or doses or dosing rates
  2. Outline risk factors not yet considered in these regimens that may explain and or be used to modify the regimen in an individualized patient at initiation or during therapy
  3. Justify an individualized regimen choice from current practices on the basis of location, supply, patient prognosis, risk factors and patient response

Speaker(s)/Author(s)

Frank P. Paloucek, Pharm.D. FASHP, FAACT, DPLA, DABAT
Clinical Professor Department of Pharmacy Practice, UIC College of Pharmacy; Attending Toxicologist, Toxikon Consortium

Activity Number

0062-9999-22-056-L01-P
Date: 03/11/22
Time: 05:30 PM - 06:00 PM

CE Hours

0.50
 

 

 

At the completion of this activity, the participant will be able to:
  1. Discuss the key differences in using lipoglycopeptides compared to traditional therapies for acute bacterial skin and skin structure infections (ABSSSI)
  2. Determine the clinical and financial impacts of using a lipoglycopeptide protocol in the Emergency Department

Speaker(s)/Author(s)

Abby M. Bailey, PharmD, BCCCP
Clinical Pharmacy Specialist & Clinical Coordinator, Emergency Medicine, University of Kentucky

Activity Number

0062-9999-22-057-L01-P
Date: 03/12/22
Time: 01:00 PM - 01:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Describe the pathological processes underlying the formation of cerebral edema
  2. Compare the available literature supporting the use of hypertonic saline and mannitol in the management of cerebral edema
  3. Identify important considerations for implementing osmotherapy in the emergency department

Speaker(s)/Author(s)

Kyle Weant, PharmD, BCPS, BCCCP, FCCP
Clinical Assistant Professor and Emergency Medicine Clinical Pharmacy Specialist, University of South Carolina College of Pharmacy

Activity Number

0062-9999-22-058-L01-P
Date: 03/12/22
Time: 01:30 PM - 02:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Identify non-opioid analgesic modalities available in the Emergency Department (ED)
  2. Evaluate advantages and disadvantages of commonly used non-opioid therapies in the ED based on the up-to-date evidence

Speaker(s)/Author(s)

Sergey M. Motov, MD FAAEM
Research Director - Department of Emergency Medicine, Maimonides Medical Center; Chair, Institutional Review Board, Maimonides Medical Center

Activity Number

0062-9999-22-059-L08-P
Date: 03/12/22
Time: 02:00 PM - 02:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Describe buprenorphine induction strategies in the Emergency Department (ED)
  2. Summarize monitoring and dose titration of buprenorphine
  3. Discuss transitions of care for the patients initiated on buprenorphine in the ED

Speaker(s)/Author(s)

David E. Zimmerman, PharmD, BCCCP
Associate Professor of Pharmacy at Duquesne University; EM Pharmacist at UPMC-Mercy Hospital

Activity Number

0062-9999-22-060-L08-P
Date: 03/12/22
Time: 02:30 PM - 03:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Review the etiology and pathophysiology of trauma induced coagulopathy
  2. Recall the pharmacology of tranexamic acid (TXA)
  3. Analyze the literature regarding the use of TXA in trauma patients

Speaker(s)/Author(s)

Ruben Santiago, PharmD
Clinical Pharmacist, Emergency Medicine, Jackson Memorial Hospital

Activity Number

0062-9999-22-061-L01-P
Date: 03/12/22
Time: 04:00 PM - 05:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Review pathophysiology and assessment of acute alcohol withdrawal syndrome
  2. Discuss the pharmacology and pharmacokinetics of common medications used in alcohol withdrawal
  3. Analyze the clinical literature regarding management of alcohol withdrawal using phenobarbital

Speaker(s)/Author(s)

Jimmy L. Pruitt III, PharmD, BCPS
Emergency Medicine Clinical Pharmacy Specialist

Activity Number

0062-9999-22-062-L01-P
Date: 03/12/22
Time: 04:30 PM - 05:00 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Interpret practical laboratory values helpful for evaluating the degree of anticoagulation in the acute care setting
  2. Describe the clinical pharmacology of available anticoagulants and reversal agents
  3. Evaluate potential agents and strategies for reversal of anticoagulants including warfarin, direct thrombin inhibitors, and direct factor Xa inhibitors

Speaker(s)/Author(s)

Bryan D. Hayes, PharmD, DABAT, FAACT, FASHP
Pharmacist, Emergency Medicine and Toxicology - Massachusetts General Hospital

Activity Number

0062-9999-22-063-L01-P
Date: 03/12/22
Time: 05:00 PM - 05:30 PM

CE Hours

0.50
 

 

At the completion of this activity, the participant will be able to:
  1. Describe the main causes of acute agitation in the Emergency Department (ED)
  2. Discuss the various treatment options for the acutely agitated patient in ED
  3. Describe the onset of action and adverse effects of the chemical sedatives used for acute agitation

Speaker(s)/Author(s)

Amy Thomson, MSHP
Senior Specialist in Poisons Information, Education and Training, New South Wales Poisons Information Centre; Specialist Emergency Medicine Pharmacist, Northern Beaches Hospital

Activity Number

0062-9999-22-064-L01-P
Date: 03/12/22
Time: 05:30 PM - 06:00 PM

CE Hours

0.50
 



 
University of South Carolina College of Pharmacy | 715 Sumter Street, Coker Life Sciences, Columbia, SC 29208 | 803-777-9979 | CE@cop.sc.edu
 
Powered By: Learning ExpressCE
Copyright © 2024 UofSC College of Pharmacy Continuing Education. All Rights Reserved.
About Us Privacy Policy Terms of Service